LSBCF (LakeShore Biopharma Co) Effective Interest Rate on Debt %: 4.63% (As of Mar. 2025)


What is LakeShore Biopharma Co Effective Interest Rate on Debt %?

LakeShore Biopharma Co LSBCF Effective Interest Rate on Debt % is 4.63% as of Mar. 2025.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. LakeShore Biopharma Co's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was $2.53 Mil. LakeShore Biopharma Co's average total debt for the quarter that ended in Mar. 2025 was $54.63 Mil. Therefore, LakeShore Biopharma Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 4.63%.

LakeShore Biopharma Co  (OTCPK:LSBCF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

LakeShore Biopharma Co Effective Interest Rate on Debt % Related Terms

LakeShore Biopharma Co Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Effective Interest Rate on Debt % Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Effective Interest Rate on Debt %
161.02 1.36 6.77 9.38 3.74

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only 6.57 4.79 12.92 3.35 4.63

LSBCF vs ACUT, PPCB, ENSC: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Effective Interest Rate on Debt % falls into.


LakeShore Biopharma Co Effective Interest Rate on Debt % Calculation

LakeShore Biopharma Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Mar. 2024 )+Total Debt  (A: Mar. 2025 ))/ count )
=-1  *  -2.171/( (58.942+57.164)/ 2 )
=-1  *  -2.171/58.053
=3.74 %

where

Total Debt  (A: Mar. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.993 + 44.949
=58.942

Total Debt  (A: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=3.242 + 53.922
=57.164

LakeShore Biopharma Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Sep. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  -2.528/( (52.089+57.164)/ 2 )
=-1  *  -2.528/54.6265
=4.63 %

where

Total Debt  (Q: Sep. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=11.149 + 40.94
=52.089

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=3.242 + 53.922
=57.164

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 4.63% mean?
LakeShore Biopharma Co (LSBCF) has a Effective Interest Rate on Debt % of 4.63% as of Mar. 2025. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Effective Interest Rate on Debt % too high?
LakeShore Biopharma Co's current Effective Interest Rate on Debt % is 4.63%.
How does LakeShore Biopharma Co's Effective Interest Rate on Debt % compare to ACUT and PPCB?
LakeShore Biopharma Co's Effective Interest Rate on Debt % of 4.63% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Effective Interest Rate on Debt % is 4.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Effective Interest Rate on Debt % of 4.63%. The current Effective Interest Rate on Debt % is 4.63%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Effective Interest Rate on Debt % is 4.63% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.